Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)
Clinical trial NCT00751738 · COMPLETED
Trial details
- NCT number
- NCT00751738
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2005-10-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.